Tg(tetO-Nras*Q61K)#Lc
Transgene Detail
|
|
| Symbol: |
Tg(tetO-Nras*Q61K)#Lc |
| Name: |
transgene insertion, Lynda Chin |
| MGI ID: |
MGI:5818045 |
| Synonyms: |
TetO-iNRASQ61K |
| Transgene: |
Tg(tetO-Nras*Q61K)#Lc Location: unknown
|
| Alliance: |
Tg(tetO-Nras*Q61K)#Lc page
|
|
| Strain of Origin: |
Not Specified
|
|
| Transgene Type: |
|
Transgenic (Humanized sequence, Inducible, Inserted expressed sequence) |
| Inducer: |
|
doxycycline/tetracycline |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: The tetracycline operon drives the inducible expression of a cDNA with nucleotide substitutions that result in the amino acid substitution of lysine for glutamine at position 61 (Q61K).
(J:238049)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
| Original: |
J:238049 Kwong LN, et al., Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma. Nat Med. 2012 Oct;18(10):1503-10 |
| All: |
3 reference(s) |
|
Analysis Tools
